Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Loading IDRA News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.31%||72.13||1.0%||$655.07m|
|ARIA||ARIAD Pharmaceuticals, Inc.||0.23%||23.70||16.4%||$416.43m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.42%||135.87||2.5%||$385.05m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.08%||362.95||2.5%||$365.07m|
|CLVS||Clovis Oncology, Inc.||0.64%||56.62||17.9%||$166.73m|
|VRTX||Vertex Pharmaceuticals Incorporated||1.19%||82.52||2.1%||$152.50m|
|SRPT||Sarepta Therapeutics, Inc.||-0.42%||35.98||16.8%||$110.90m|
|ACAD||ACADIA Pharmaceuticals Inc.||3.06%||32.31||18.3%||$110.16m|
|IONS||Ionis Pharmaceuticals, Inc.||1.12%||47.14||8.9%||$110.11m|
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. The company uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. Idera Pharmaceuticals was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.